Skip to main content

Psychotic disorders

This section focuses on psychotic disorders. Topics of interest include, but are not limited to, schizophrenia, antipsychotics, biochemistry, hallucinations, delusions, neurocognitive functioning and brain imaging.

Page 9 of 9

  1. The authors sought to compare gray matter changes in First Episode Schizophrenia (FES) compared with Fronto-Temporal Lobar Degeneration (FTLD) using meta-analytic methods applied to neuro-imaging studies.

    Authors: Bayanne Olabi, Ian Ellison-Wright, Ed Bullmore and Stephen M Lawrie

    Citation: BMC Psychiatry 2012 12:104

    Content type: Research article

    Published on:

  2. The ultra high risk state for psychosis has not been studied in young offender populations. Prison populations have higher rates of psychiatric morbidity and substance use disorders. Due to the age profile of ...

    Authors: Darran Flynn, Damian Smith, Luke Quirke, Stephen Monks and Harry G Kennedy

    Citation: BMC Psychiatry 2012 12:100

    Content type: Research article

    Published on:

  4. To fully assess the various dimensions affected by schizophrenia, clinical trials often include multiple scales measuring various symptom profiles, cognition, quality of life, subjective well-being, and functi...

    Authors: Lei Chen, Glenn Phillips, Joseph Johnston, Bruce J Kinon, Haya Ascher-Svanum, Sara Kollack-Walker, Paul Succop and Dieter Naber

    Citation: BMC Psychiatry 2011 11:203

    Content type: Research article

    Published on:

  5. The benefits of some second-generation antipsychotics (SGAs) must be weighed against the increased risk for diabetes mellitus. This study examines whether the association between SGAs and diabetes differs by d...

    Authors: Marianne Ulcickas Yood, Gerald N DeLorenze, Charles P Quesenberry Jr, Susan A Oliveria, Ai-Lin Tsai, Edward Kim, Mark J Cziraky, Robert D McQuade, John W Newcomer and Gilbert J L'Italien

    Citation: BMC Psychiatry 2011 11:197

    Content type: Research article

    Published on:

  6. This observational study explored the prevalence of metabolic syndrome (MetS) in adult in- and outpatients with untreated or treated schizophrenia at baseline, and month-3 after initiation or switch of antipsy...

    Authors: Susanne Kraemer, Anette Minarzyk, Thomas Forst, Daniel Kopf and Hans-Peter Hundemer

    Citation: BMC Psychiatry 2011 11:173

    Content type: Research article

    Published on:

  7. The Beck Cognitive Insight Scale (BCIS) was designed for the assessment of the cognitive processes involved in self-reflection and the ability to modify erroneous beliefs and misinterpretations. Studies invest...

    Authors: Yu-Chen Kao, Tzong-Shi Wang, Chien-Wen Lu and Yia-Ping Liu

    Citation: BMC Psychiatry 2011 11:170

    Content type: Research article

    Published on:

  8. Schizophrenia is associated with a two to three fold excess mortality. Both natural and unnatural causes were reported. However, there is dearth of evidence from low and middle income (LAMIC) countries, partic...

    Authors: Solomon Teferra, Teshome Shibre, Abebaw Fekadu, Girmay Medhin, Asfaw Wakwoya, Atalay Alem, Gunnar Kullgren and Lars Jacobsson

    Citation: BMC Psychiatry 2011 11:165

    Content type: Research article

    Published on:

  9. Low levels of self-esteem have been implicated as both a cause and a consequence of severe mental disorders. The main aims of the study were to examine whether premorbid adjustment has an impact on the subject...

    Authors: Kristin Lie Romm, Jan Ivar Rossberg, Charlotte Fredslund Hansen, Elisabeth Haug, Ole A Andreassen and Ingrid Melle

    Citation: BMC Psychiatry 2011 11:136

    Content type: Research article

    Published on:

  10. The aim of this study was to determine glutathione levels and antioxidant enzyme activities in the drug-naive first-episode patients with schizophrenia in comparison with healthy control subjects.

    Authors: Monia Raffa, Fatma Atig, Ahmed Mhalla, Abdelhamid Kerkeni and Anwar Mechri

    Citation: BMC Psychiatry 2011 11:124

    Content type: Research article

    Published on:

Submit manuscript

Follow

2019 Journal Metrics

BMC Psychiatry

ISSN: 1471-244X

Contact us